We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Pci-pal Plc | LSE:PCIP | London | Ordinary Share | GB0009737155 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.50 | -0.79% | 63.00 | 62.00 | 64.00 | 63.50 | 62.50 | 63.50 | 93,973 | 14:33:10 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Business Services, Nec | 17.96M | -1.18M | -0.0163 | -38.65 | 45.99M |
Date | Subject | Author | Discuss |
---|---|---|---|
11/12/2024 17:18 | Anyone attend the AGM and have any notes to share? | powlert | |
11/12/2024 07:18 | All looking good on the path to increasing revenue and cashflow. | this_is_me | |
12/11/2024 12:55 | Why the sudden buying spree against a falling market? This started Midday yesterday. Are they going to make an anouncement very soon? We are not expecting any! This is my observation about this company. | yousif | |
04/11/2024 13:32 | I agree, seems likely this was known a little early. But nonetheless good to see management releasing news like this. Keep the positive share price momentum going. Stock still exceptionally cheap - lock it away and reassess at 120p. | powlert | |
04/11/2024 09:24 | Given the retrace today, and that it was announced as a NON-RNS I guess this was known before today. But still decent news or at least a land mine avoided. From a YTD low to a YTD high in a few weeks is decent. Particularly as I have had a couple do the oppposite recently.. | dr biotech | |
04/11/2024 08:47 | Yes, closing above 65p-66p would be handy | adamb1978 | |
04/11/2024 08:22 | A bit of good news and a breakout from the trading range that it has been in for about a year. | this_is_me | |
01/11/2024 23:38 | Regarding the PEG ratio, as Adam says, 4p in earnings should be completely achievable in FY26. With 1-2p in FY25, you tell me what the PEG is. | powlert | |
01/11/2024 23:34 | Decent volume today. If we can break through 66 then should be off to the races. | powlert | |
01/11/2024 14:21 | We are back to the top of this year's trading range with things looking good so with any luck, we could see a breqkout from here. | this_is_me | |
01/11/2024 09:30 | Hi Simon THanks for posting though those figures from CAV are hopelessly conservative. They imply a rapidly increasing cost base though the company has said taht their rate of headcount growth will moderate and it hasnt even been that fast in the past!! I think FY26 EPS will be more like 4p. Adam | adamb1978 | |
01/11/2024 06:56 | Cavendish - 22/10/24: FY 2026 -T/O = £25.5m -Adj EBITDA = £2.6m -Adj EBIT = £0.7m -Adj PBT = £0.6m -Adj EPS = 0.8p -Net Cash = £5m | simon gordon | |
01/11/2024 00:10 | What do people think the PEG ratio is then, going forward? | cyberbub | |
01/11/2024 00:01 | That is exceptionally cheap for a software business growing revenue at 20% with even faster earnings growth. Should be 30-40x earnings. | powlert | |
31/10/2024 23:14 | Have this on my secondary watchlist, I did own a few at one point. Looks like the company is free to move forward now, but if the EPS isn't expected to hit 4p for another 12-18 months, OK Mr Market looks forward to an extent, but a P/E of 16 on today's share price isn't super cheap? Unless people are waiting for a takeover as some have suggested, on the basis of a cashflow multiple and long-term forecast growth? | cyberbub | |
31/10/2024 13:55 | Probably me recycling some of my ECK gains to maintain exposure to the sector. | wjccghcc | |
31/10/2024 13:40 | re 'falling market': I think thats more due to the budget. I dont think many people were buying in Sept/Oct but now more will be Reason for buying here is that valuation is very cheap. | adamb1978 | |
31/10/2024 13:09 | The volumes here are so miniscule that it just takes one person deciding they want to buy/sell to move the price. Only £30k traded today. Peanuts for some. | powlert | |
31/10/2024 13:02 | Somebody is buying !!! Any particular reason? Results just been announced and we are not expecting new news soon. Furthermore, it is a falling market! Can not explain it. | yousif | |
30/10/2024 12:45 | Thanks - hadnt seen that but yes, it further shows here that the valuation upside here is considerable | adamb1978 | |
30/10/2024 10:33 | Eckoh acquired at almost 4x revenue. And here PCIP, a better business, sits at sub-2x. Who says markets are efficient. | powlert | |
27/10/2024 17:24 | Investor call on Friday is worth listening too. Key comments in my view were: - Can grow TACV at 18%-20% p.a. as baseline "over the coming years" with upside from there based on product portfolio growth etc - Damage on booked ACV in FY24 was Q1. Since then had 4 quarters ahead of budget - Also suggested holding back some investment in product etc in order to consistently grow earnings. In the US this company wouldnt do that however it suggests we should see nice earnings growth over the coming years Am hoping that the headwinds are now behind us - litigation solved, profitable, cash generative, cash in the bank etc - and that this will now be one that can be held without too many worries | adamb1978 | |
25/10/2024 11:37 | Imagine what will happen when we get some actual volume. | powlert |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions